| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efdfc7e7bb9f74e4c2cf7801fa9764a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_413d88d9c15118daa1ea644115cd0da1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb25bf01598c6c7faf929ecb4727d01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cbdf9c8d70e2448cef1dbc1d0aa766f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a7f82918104224b0cc78fd4e176b8cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14778a8d1ac7acf7371cbcef62dd0268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6597a6b42e091db733e93a3b1ba3d071 |
| publicationDate |
2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8741332-B2 |
| titleOfInvention |
Compositions and methods for dermally treating neuropathic pain |
| abstract |
The present invention is drawn to adhesive solidifying formulations for treating neuropathic pain. The formulation can include a drug suitable for treating neuropathic pain, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010267678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022395469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021101777-A1 |
| priorityDate |
2004-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |